SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001551163-18-000148
Filing Date
2018-09-28
Accepted
2018-09-28 15:37:07
Documents
29
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 sgbi10k2018_final_20180928ve.htm 10-K 605499
2 exhibit31.01-rule13a-14ceo_2.htm EX-31 6746
3 exhibit31.02-rule13a-14cfo_2.htm EX-31 7344
4 ex21.02vedgar1.htm EX-21 2650
  Complete submission text file 0001551163-18-000148.txt   1298104

Data Files

Seq Description Document Type Size
5 sgbi-20180630.xml EX-101.INS 131866
6 sgbi-20180630.xsd EX-101.SCH 8436
7 sgbi-20180630_cal.xml EX-101.CAL 16005
8 sgbi-20180630_def.xml EX-101.DEF 5967
9 sgbi-20180630_lab.xml EX-101.LAB 61760
10 sgbi-20180630_pre.xml EX-101.PRE 48118
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-29233 | Film No.: 181094019
SIC: 2834 Pharmaceutical Preparations